Pub Date : 2021-09-15DOI: 10.1007/978-3-030-53370-0
J. Faintuch, S. Faintuch
{"title":"Obesity and Diabetes: Scientific Advances and Best Practice","authors":"J. Faintuch, S. Faintuch","doi":"10.1007/978-3-030-53370-0","DOIUrl":"https://doi.org/10.1007/978-3-030-53370-0","url":null,"abstract":"","PeriodicalId":91086,"journal":{"name":"Integrative obesity and diabetes","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89152003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.1007/978-3-030-53370-0_47
M. Finessi, V. Liberini, D. Deandreis
{"title":"Cancer Staging with 18F-FDG PET/CT in Hyperglycemic Patients","authors":"M. Finessi, V. Liberini, D. Deandreis","doi":"10.1007/978-3-030-53370-0_47","DOIUrl":"https://doi.org/10.1007/978-3-030-53370-0_47","url":null,"abstract":"","PeriodicalId":91086,"journal":{"name":"Integrative obesity and diabetes","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77443933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.1007/978-3-030-53370-0_31
M. Tadic, C. Cuspidi
{"title":"Heart Failure and the Obesity Paradox","authors":"M. Tadic, C. Cuspidi","doi":"10.1007/978-3-030-53370-0_31","DOIUrl":"https://doi.org/10.1007/978-3-030-53370-0_31","url":null,"abstract":"","PeriodicalId":91086,"journal":{"name":"Integrative obesity and diabetes","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91105476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.1007/978-3-030-53370-0_42
J. Gunst, G. Berghe
{"title":"Glucose Control in the Intensive Care Unit","authors":"J. Gunst, G. Berghe","doi":"10.1007/978-3-030-53370-0_42","DOIUrl":"https://doi.org/10.1007/978-3-030-53370-0_42","url":null,"abstract":"","PeriodicalId":91086,"journal":{"name":"Integrative obesity and diabetes","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82051008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.1007/978-3-030-53370-0_62
Sonmoon Mohapatra, C. Pitchumoni
{"title":"Malnutrition in Obesity","authors":"Sonmoon Mohapatra, C. Pitchumoni","doi":"10.1007/978-3-030-53370-0_62","DOIUrl":"https://doi.org/10.1007/978-3-030-53370-0_62","url":null,"abstract":"","PeriodicalId":91086,"journal":{"name":"Integrative obesity and diabetes","volume":"2 3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83269159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.1007/978-3-030-53370-0_59
Candice Silverman, A. Isaacs, N. Tan
{"title":"Robotic Bariatric Surgery","authors":"Candice Silverman, A. Isaacs, N. Tan","doi":"10.1007/978-3-030-53370-0_59","DOIUrl":"https://doi.org/10.1007/978-3-030-53370-0_59","url":null,"abstract":"","PeriodicalId":91086,"journal":{"name":"Integrative obesity and diabetes","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78363626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-04-01Epub Date: 2017-03-06DOI: 10.15761/IOD.1000170
Kyle W Morse, Nerys M Astbury, Alexandra Walczyszyn, Sami A Hashim, Allan Geliebter
The purpose of this preliminary study was to investigate changes in plasma concentrations of zinc-α2-glycoprotein (ZAG), a lipid mobilizing hormone, in obese subjects following Roux-En-Y Gastric Bypass (RYGB) surgery or a very low calorie diet (VLCD). Fasting blood concentrations and anthropometric measurements were measured pre and 12 weeks post intervention. 14 healthy, obese individuals underwent either RYGB (N=6) surgery or a VLCD (N=8). Body composition and fasting plasma ZAG concentrations were measured at baseline (pre) and 12 weeks post intervention (post). At pre-intervention baseline, there was no difference in plasma ZAG between the two intervention groups. Post-intervention, there was a significant overall reduction (F(1,11) = 32.8, p<0.001) in plasma ZAG, which was significant only within the RYGB group from pre to post intervention (33.2 ± 5.7 μg/ml to 26.7 ± 4.8 μg/ml (p<0.015)) and significantly greater than the change within the VLCD group. The change in ZAG was inversely correlated across groups with BMI reduction (r= -0.60, p<0.05), % body fat reduction (r= -0.68, p<0.015), reduction in weight (r= -0.58, p<0.05), and % weight loss (r= -0.70, p<0.05). Overall, subjects who underwent RYGB or VLCD had a significant reduction in plasma ZAG. This reduction was significant within the RYGB group alone, who lost a larger amount of weight than the VLCD group, which suggests that ZAG may have a protective effect during marked weight loss.
{"title":"Changes in zinc-α2-glycoprotein (ZAG) plasma concentrations pre and post Roux-En-Y gastric bypass surgery (RYGB) or a very low calorie (VLCD) diet in clinically severe obese patients: Preliminary Study.","authors":"Kyle W Morse, Nerys M Astbury, Alexandra Walczyszyn, Sami A Hashim, Allan Geliebter","doi":"10.15761/IOD.1000170","DOIUrl":"https://doi.org/10.15761/IOD.1000170","url":null,"abstract":"<p><p>The purpose of this preliminary study was to investigate changes in plasma concentrations of zinc-α2-glycoprotein (ZAG), a lipid mobilizing hormone, in obese subjects following Roux-En-Y Gastric Bypass (RYGB) surgery or a very low calorie diet (VLCD). Fasting blood concentrations and anthropometric measurements were measured pre and 12 weeks post intervention. 14 healthy, obese individuals underwent either RYGB (N=6) surgery or a VLCD (N=8). Body composition and fasting plasma ZAG concentrations were measured at baseline (pre) and 12 weeks post intervention (post). At pre-intervention baseline, there was no difference in plasma ZAG between the two intervention groups. Post-intervention, there was a significant overall reduction (F(1,11) = 32.8, <i>p</i><0.001) in plasma ZAG, which was significant only within the RYGB group from pre to post intervention (33.2 ± 5.7 μg/ml to 26.7 ± 4.8 μg/ml (<i>p</i><0.015)) and significantly greater than the change within the VLCD group. The change in ZAG was inversely correlated across groups with BMI reduction (r= -0.60, <i>p</i><0.05), % body fat reduction (r= -0.68, <i>p</i><0.015), reduction in weight (r= -0.58, <i>p</i><0.05), and % weight loss (r= -0.70, <i>p</i><0.05). Overall, subjects who underwent RYGB or VLCD had a significant reduction in plasma ZAG. This reduction was significant within the RYGB group alone, who lost a larger amount of weight than the VLCD group, which suggests that ZAG may have a protective effect during marked weight loss.</p>","PeriodicalId":91086,"journal":{"name":"Integrative obesity and diabetes","volume":"3 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777576/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35765644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号